15 healthtech investors fund Riyadh startups in 2026. STV, Sanabil, and Wa'ed Ventures back digital health and biotech. Saudi's digital health market reached $4.4B in 2025 as care goes online.
Saudi Arabia is rebuilding healthcare around digital tools. Vision 2030 keeps pushing private money into the sector.
STV and Sanabil write the biggest digital health cheques. Wa'ed and Lifera back biotech and local manufacturing.
Most rounds need clinical proof, approval, and data security. Ellty tracks every data room open from these funds.
This guide lists 15 active Riyadh healthtech investors in 2026.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| STV | Growth VC | $5M-$50M | Digital health, SaaS, fintech | stv.vc |
| Sanabil Investments | Sovereign / govt fund | $2.5M-$100M+ | Healthcare, digital health | sanabil.com |
| Wa'ed Ventures | Corporate VC | $1M-$20M | Biotech, healthtech, deep tech | waed.com |
| Saudi Venture Capital | Fund of funds | LP commitments | Healthtech, multi-sector | svc.com.sa |
| Jada Fund of Funds | Fund of funds | LP commitments | Healthtech, multi-sector | jada.com.sa |
| Impact46 | Seed to pre-IPO VC | $1M-$50M+ | Healthtech, consumer, tech | impact46.sa |
| Merak Capital | Early-stage VC | $1M-$15M | Healthtech, tech, digital | merak.capital |
| Vision Ventures | Seed / Series A VC | $250K-$5M | Digital health, tech | vision.vc |
| Nama Ventures | Pre-seed / Seed VC | $100K-$2M | Healthtech, SaaS, tech | nama.vc |
| Raed Ventures | Seed / Series A VC | $500K-$10M | SaaS, health services, fintech | raed.vc |
| Sanabil 500 MENA | Accelerator + seed fund | $100K-$500K | Healthtech, multi-sector | 500.co |
| Shorooq Partners | Seed to Series B VC | $1M-$20M | Healthtech, fintech, tech | shorooq.com |
| VentureSouq | Seed / Series A VC | $250K-$5M | Fintech, healthtech, climate | venturesouq.com |
| Lifera | PIF biopharma arm | Strategic deals | Biopharma, biotech, CDMO | lifera.com |
| Foundation Holdings | Healthcare PE/VC | $5M-$50M+ | Healthcare, digital health | foundationholdings.com |
Run your Riyadh healthtech raise tight
Health funds open your clinical data and approvals first. Ellty logs every view.
Start free 14-day trialWhat a Saudi healthtech VC backs
A healthtech investor backs digital health and medtech. In Saudi that means clinical proof and an SFDA path.
Most Riyadh health VCs write seed and Series A rounds. Strong security on patient data is now a hard must.
They want real outcomes, retention, and a clear payer. Founders pitching Abu Dhabi AI investors face a similar bar.
Ellty gives each fund one trackable link and logs every open. You see who studied your clinical data before the call.
Saudi innovation is no longer following global trends, it is setting them.
15 Riyadh healthtech investors
1. STV
STV is MENA's largest tech VC and a Riyadh healthtech backer.
Recent Activity: Deploying its STV V fund across Saudi tech, with digital health among its targets
LinkedIn: STV LinkedIn
Sector Focus: Digital health, SaaS, fintech
Stage Focus: Series A to growth
Location: Riyadh, Saudi Arabia
Website: stv.vc
2. Sanabil Investments
Sanabil is PIF's investor running a health venture studio.
Recent Activity: Launched a venture studio with Redesign Health, first spinout Nuxera AI raised $2.5M
LinkedIn: Sanabil Investments LinkedIn
Sector Focus: Healthcare, digital health, multi-sector
Stage Focus: Pre-seed to growth
Location: Riyadh, Saudi Arabia
Website: sanabil.com
3. Wa'ed Ventures
Wa'ed Ventures is Aramco's $500M VC backing Saudi biotech.
Recent Activity: Led a $10M pre-Series A in cell-therapy biotech Kure Cells in October 2025
LinkedIn: Wa'ed Ventures LinkedIn
Sector Focus: Biotech, healthtech, deep tech
Stage Focus: Seed to Series B
Location: Dhahran, Saudi Arabia
Website: waed.com
4. Saudi Venture Capital
Saudi Venture Capital is a government fund of funds backing health VCs.
Recent Activity: An LP across Saudi funds with healthtech exposure, with $2B+ committed since 2018
LinkedIn: Saudi Venture Capital LinkedIn
Sector Focus: Healthtech, multi-sector
Stage Focus: Fund of funds
Location: Riyadh, Saudi Arabia
Website: svc.com.sa
5. Jada Fund of Funds
Jada is a PIF fund of funds anchoring Saudi health VCs.
Recent Activity: Commits capital to local VCs with digital health and biotech in their portfolios
LinkedIn: Jada LinkedIn
Sector Focus: Healthtech, multi-sector
Stage Focus: Fund of funds
Location: Riyadh, Saudi Arabia
Website: jada.com.sa
6. Impact46
Impact46 is a Riyadh VC backing Saudi healthtech startups.
Recent Activity: Manages $200M+ across theme funds, active across Saudi tech rounds in 2025
LinkedIn: Impact46 LinkedIn
Sector Focus: Healthtech, consumer, tech
Stage Focus: Seed to pre-IPO
Location: Riyadh, Saudi Arabia
Website: impact46.sa
Share clinical data and track every VC open
Ellty shows when Sanabil or Wa'ed opens your clinical data and deck. Follow up fast.
Start free 14-day trial7. Merak Capital
Merak Capital is a Riyadh VC investing in healthtech and tech.
Recent Activity: An active Saudi tech investor with digital health among its portfolio sectors
LinkedIn: Merak Capital LinkedIn
Sector Focus: Healthtech, tech, digital
Stage Focus: Seed to Series B
Location: Riyadh, Saudi Arabia
Website: merak.capital
8. Vision Ventures
Vision Ventures is one of Saudi Arabia's earliest VC firms.
Recent Activity: An active early-stage Saudi tech investor with digital health exposure
LinkedIn: Vision Ventures LinkedIn
Sector Focus: Digital health, tech
Stage Focus: Seed to Series A
Location: Khobar / Riyadh
Website: vision.vc
9. Nama Ventures
Nama Ventures is a Riyadh pre-seed fund backing health founders.
Recent Activity: An active pre-seed and seed backer of Saudi healthtech and SaaS startups
LinkedIn: Nama Ventures LinkedIn
Sector Focus: Healthtech, SaaS, tech
Stage Focus: Pre-seed, seed
Location: Riyadh, Saudi Arabia
Website: nama.vc
10. Raed Ventures
Raed Ventures backs Saudi seed and Series A health startups.
Recent Activity: An active Saudi early-stage investor across SaaS and health-enabled services
LinkedIn: Raed Ventures LinkedIn
Sector Focus: SaaS, health services, fintech
Stage Focus: Seed, Series A
Location: Riyadh, Saudi Arabia
Website: raed.vc
11. Sanabil 500 MENA
Sanabil 500 MENA runs Riyadh's most active seed accelerator.
Recent Activity: Ran 2025 accelerator cohorts that included Saudi healthtech startups
LinkedIn: Sanabil 500 MENA LinkedIn
Sector Focus: Healthtech, multi-sector
Stage Focus: Pre-seed, seed
Location: Riyadh, Saudi Arabia
Website: 500.co
12. Shorooq Partners
Shorooq Partners is a major MENA VC active in Saudi health.
Recent Activity: Expanded its Saudi presence in 2025 with healthtech among its sectors
LinkedIn: Shorooq Partners LinkedIn
Sector Focus: Healthtech, fintech, tech
Stage Focus: Seed to Series B
Location: Abu Dhabi / KSA-active
Website: shorooq.com
13. VentureSouq
VentureSouq backs Saudi fintech and digital health founders.
Recent Activity: An active MENA investor with healthtech among its 2025 focus areas
LinkedIn: VentureSouq LinkedIn
Sector Focus: Fintech, healthtech, climate
Stage Focus: Seed, Series A
Location: Dubai / KSA-active
Website: venturesouq.com
14. Lifera
Lifera is PIF's biopharma arm localizing Saudi drug production.
Recent Activity: Formed a $30M genetic-testing JV with CENTOGENE to scale multiomics in KSA
LinkedIn: Lifera LinkedIn
Sector Focus: Biopharma, biotech, CDMO
Stage Focus: Strategic, corporate
Location: Riyadh, Saudi Arabia
Website: lifera.com
15. Foundation Holdings
Foundation Holdings is a GCC healthcare-focused investor.
Recent Activity: A healthcare investor active across the GCC, an earlier lead backer of Altibbi
LinkedIn: Foundation Holdings LinkedIn
Sector Focus: Healthcare, digital health
Stage Focus: Growth, Series B+
Location: Dubai / GCC-active
Website: foundationholdings.com
Vision 2030 and digital health
Vision 2030 made digital health a national priority. The Kingdom is privatizing parts of its health system.
That pulls private capital toward Riyadh health startups. Sanabil and Wa'ed Ventures together lead much of it.
Founders share clinical data and metrics with these funds. Keep board and investor relations updates current.
Run IT due diligence on your systems quite early. Health funds expect clean and secure infrastructure.
SFDA rules and approvals
Every Saudi health product runs under the SFDA rules. Approval gates most of the digital health funding.
Investors check your regulatory path before they commit. Vague compliance ends most health pitches quite early.
Keep approvals and clinical files behind secure file sharing. Ellty shows you exactly who opened each shared file.
Send monthly trial and approval updates to keep funds warm. Trackable Ellty links show you who still reads them.
Telehealth and patient data
Telehealth went mainstream in Saudi Arabia after 2020. Apps like Cura now serve millions of Saudi patients.
Patient data is the most sensitive asset you hold. A single data leak can end a health startup fast.
Lock down shared records with screenshot protection. Ellty controls exactly who can view and download.
Work through cybersecurity due diligence before you raise. It maps closely to what Sanabil and Wa'ed expect now.
How to pitch a Riyadh healthtech investor
Lead with clinical proof, an SFDA path, and data security.
- 1.Show clinical outcomes, not just a demo.Saudi health VCs fund real results.
- 2.Map your SFDA approval path early.A clear regulatory plan unlocks funds.
- 3.Prove your data security from day one.Patient data must be locked down tight.
- 4.Share one Ellty link per fund and track opens.Follow up when a VC reads your data.
How Ellty helps you land a healthtech investor in Riyadh
You've found your Riyadh healthtech investors already. Set up a data room before your first pitch.
- 1.Upload clinical data, approvals, and metrics to Ellty.Set NDA-gated access per investor.
- 2.Share a unique trackable link with each fund.Each fund gets one link. Ellty logs every open.
- 3.Track opens and follow up the moment they read.Use Ellty analytics to time your follow-up.
Riyadh healthtech investor questions
- VCs, sovereign funds, and accelerators. STV, Sanabil, and Wa'ed lead the sector.
- Cheques run $250K to $30M in 2026. Strategic funds write much larger ones.
- Clinical proof, an SFDA path, and security. Demos without outcomes rarely win.
- Not always, but a clear path helps a lot. Most funds ask about it early.
- The market topped $4B in 2025. Vision 2030 keeps it growing fast.
- Before outreach starts. Track who opens your clinical and approval docs.
